Royalty Pharma plc Class A Ordinary Shares (NASDAQ: RPRX) last traded at $61.31, up 1.21% on the session. The quote above updates while this page is open; the figures below are drawn from Royalty Pharma plc Class A Ordinary Shares’s own filings and are restated only when a new one is published.
Royalty Pharma plc Class A Ordinary Shares trades on NASDAQ under the ticker RPRX. Its market capitalisation is $34.14 billion.
Valuation measures for Royalty Pharma plc Class A Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $34.14B |
|---|---|
| Enterprise value | $43.37B |
| P/E ratio | 32.79 |
| Price / sales | 13.46 |
| Beta | 0.24 |
Trailing-twelve-month figures tagged in Royalty Pharma plc Class A Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $2.54B |
|---|---|
| Net income (TTM) | $812.00M |
| EPS (TTM) | $1.87 |
| Operating margin | 59.61% |
| Cash | $811.99M |
Range and volume for RPRX over the past 52 weeks.
| 52-week high | $62.13 |
|---|---|
| 52-week low | $34.08 |
| Volume | 2.26M |
| Average volume | 3.46M |
| Previous close | $60.58 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.